Elutia (ELUT) announced that it has entered into an agreement with Advantus Health Partners to provide access of Elutia’s EluPro Antibiotic Eluting BioEnvelope to Advantus’ core group purchasing organizations solutions portfolio.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELUT: